Cardiff selloff brings attractive entry point, says H.C. Wainwright
H.C. Wainwright says the “market overreaction” in shares of Cardiff Oncology (CRDF) “provides an attractive stock price entry point.” Cardiff announced that it will now share updated clinical data from...
